1. Multidimensional immunomodulation;House;J Immunotoxicol,2004
2. Note for guidance on repeated dose toxicity;EMEA,2000
3. FDA. Guidance for industry: immunotoxicology evaluation of investigational new drugs. Available from http://www.fda.gov/cder/guidance/index.htm.
4. Guidance for industry. S8 immunotoxicity studies for human pharmaceuticals;ICH (International Conference on Harmonization),2006
5. Current regulatory expectations for immunotoxicology evaluation of pharmaceuticals;Hastings,2008